The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26

被引:52
|
作者
Varasteh, Zohreh [1 ]
Mitran, Bogdan [1 ]
Rosenstrom, Ulrika [3 ]
Velikyan, Irina [1 ]
Rosestedt, Maria [1 ]
Lindeberg, Gunnar [3 ]
Sorensen, Jens [4 ]
Larhed, Mats [5 ]
Tolmachev, Vladimir [2 ]
Orlova, Anna [1 ]
机构
[1] Uppsala Univ, Fac Pharm, Dept Med Chem, Preclin PET Platform, S-75183 Uppsala, Sweden
[2] Uppsala Univ, Fac Med, Dept Immunol Genet & Pathol, S-75183 Uppsala, Sweden
[3] Uppsala Univ, Fac Pharm, Dept Med Chem, Organ Pharmaceut Chem, S-75183 Uppsala, Sweden
[4] Uppsala Univ, Nucl Med & PET, S-75183 Uppsala, Sweden
[5] Uppsala Univ, Fac Pharm, Dept Med Chem, Sci Life Lab, S-75183 Uppsala, Sweden
基金
瑞典研究理事会;
关键词
Bombesin antagonistic analog; NOTA; DOTA; NODAGA; DOTAGA; Molecular imaging; CONJUGATED BOMBESIN ANTAGONIST; POSITRON-EMISSION-TOMOGRAPHY; PET; EXPRESSION; CONSTANTS; AFFINITY; AGONISTS; BINDING; CANCER; LENGTH;
D O I
10.1016/j.nucmedbio.2014.12.009
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: Overexpression of gastrin-releasing peptide receptors (GRPR) has been reported in several cancers. Bombesin (BN) analogs are short peptides with a high affinity for GRPR. Different BN analogs were evaluated for radionuclide imaging and therapy of GRPR-expressing tumors. We have previously investigated an antagonistic analog of BN (D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2, RM26) conjugated to NOTA via a PEG(2) spacer (NOTA-PEG(2)-RM26) labeled with Ga-68, In-111 and (AlF)-F-18. Ga-68-labeled NOTA-PEG(2)-RM26 showed high tumor-to-organ ratios. Methods: The influence of different macrocyclic chelators (NOTA, NODAGA, DOTA and DOTAGA) on the targeting properties of Ga-68-labeled PEG(2)-RM26 was studied in vitro and in vivo. Results: All conjugates were labeled with generator-produced Ga-68 with high yields and demonstrated high stability and specific binding to GRPR. The IC50 values of Ga-nat-X-PEG(2)-RM26 (X = NOTA, DOTA, NODAGA, DOTAGA) were 2.3 +/- 0.2, 3.0 +/- 0.3, 2.9 +/- 0.3 and 10.0 +/- 0.6 nM, respectively. The internalization of the conjugates by PC-3 cells was low. However, the DOTA-conjugated analog demonstrated a higher internalization rate compared to other analogs. GRPR-specific uptake was found in receptor-positive normal tissues and PC-3 xenografts for all conjugates. The biodistribution of the conjugates was influenced by the choice of the chelator moiety. Although all radiotracers cleared rapidly from the blood, [Ga-68]Ga-NOTA-PEG(2)-RM26 showed significantly lower uptake in lung, muscle and bone compared to the other analogs. The uptake in tumors (5.40 +/- 1.04 %ID/g at 2 h p.i.) and the tumor-to-organ ratios (25 +/- 3, 157 +/- 23 and 39 +/- 4 for blood, muscle and bone, respectively) were significantly higher for the NOTA-conjugate than the other analogs. Conclusions: Chelators had a clear influence on the biodistribution and targeting properties of Ga-68-labeled antagonistic BN analogs. Positively charged [Ga-68]Ga-NOTA-PEG(2)-RM26 provided a low kidney radioactivity uptake, high affinity, high tumor uptake and high image contrast. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:446 / 454
页数:9
相关论文
共 50 条
  • [1] The effects of novel macrocyclic chelates on the targeting properties of the 68Ga-labeled Gastrin releasing peptide receptor antagonist RM2
    Yinwen Wang
    Hongmei Yuan
    Sufan Tang
    Yang Liu
    Ping Cai
    Nan Liu
    Yue Chen
    Zhijun Zhou
    EJNMMI Research, 13
  • [2] The effects of novel macrocyclic chelates on the targeting properties of the 68Ga-labeled Gastrin releasing peptide receptor antagonist RM2
    Wang, Yinwen
    Yuan, Hongmei
    Tang, Sufan
    Liu, Yang
    Cai, Ping
    Liu, Nan
    Chen, Yue
    Zhou, Zhijun
    EJNMMI RESEARCH, 2023, 13 (01)
  • [3] Synthesis, radiolabeling, and evaluation of gastrin releasing peptide receptor antagonist 68Ga-HBED-CC-RM26
    Satpati, Drishty
    Vats, Kusum
    Sharma, Rohit
    Kameswaran, Mythili
    Sarma, Haladhar Dev
    Dash, Ashutosh
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 (12): : 843 - 849
  • [4] PET imaging of gastrin-releasing peptide receptor with a novel 68Ga-labeled bombesin analogue
    Lau, Joseph
    Rousseau, Etienne
    Zhang, Zhengxing
    Uribe, Carlos
    Kuo, Hsiou-Ting
    Zeisler, Jutta
    Zhang, Chengcheng
    Kwon, Daniel
    Lin, Kuo-Shyan
    Benard, Francois
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S112 - S113
  • [5] Radiometal Complexes as Pharmacokinetic Modifiers: A Potent 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonist Based on the Macrocyclic Metal Chelator NODIA-Me
    Schreck, Moritz-Valentin
    Burgard, Caroline
    Schmidtke, Alexander
    Hierlmeier, Ina
    Stemler, Tobias
    Maus, Stephan
    Rosar, Florian
    Jung, Martin
    Speicher, Andreas
    Ezziddin, Samer
    Holland, Jason P.
    Bartholomae, Mark D.
    MOLECULAR PHARMACEUTICS, 2023, 20 (12) : 6463 - 6473
  • [6] Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts
    Strand, Joanna
    Honarvar, Hadis
    Perols, Anna
    Orlova, Anna
    Selvaraju, Ram Kumar
    Karlstrom, Amelie Eriksson
    Tolmachev, Vladimir
    PLOS ONE, 2013, 8 (08):
  • [7] Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist 68Ga-RM2 And PET
    Stoykow, Christian
    Erbes, Thalia
    Maecke, Helmut R.
    Bulla, Stefan
    Bartholomae, Mark
    Mayer, Sebastian
    Drendel, Vanessa
    Bronsert, Peter
    Werner, Martin
    Gitsch, Gerald
    Weber, Wolfgang A.
    Stickeler, Elmar
    Meyer, Philipp T.
    THERANOSTICS, 2016, 6 (10): : 1641 - 1650
  • [8] Clinical Translation of Gastrin Releasing Peptide Receptor Antagonist 68Ga-NOTA-RM26 in Healthy Volunteers and Prostate Cancer Patients
    Zhang, Jingjing
    Lang, Lixin
    Fan, Xinrong
    Li, Fang
    Niu, Gang
    Zhu, Zhaohui
    Chen, Xiaoyuan
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [9] Comparison of In Vitro Mouse Serum Stability of 68Ga-Labeled PSMA Targeting Conjugates of Acyclic and Macrocyclic Chelators
    Pippin, Adam
    Woolum, Karen
    Kumar, Krishan
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [10] Influence of macrocyclic chelators on biodistribution and targeting properties of 68Ga-labeled synthetic Affibody molecules. Comparison with 111In-labeled counterparts
    Strand, J.
    Honarvar, H.
    Perols, A.
    Orlova, A.
    Kumar, R.
    Karlstrom, A. Eriksson
    Tolmachev, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S220 - S220